Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04747054
Title Study on the Efficacy of Radiotherapy Added to Pembrolizumab in Newly Diagnosed Metastatic Head and Neck Cancers (PembroMetaRT)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors UNICANCER
Indications

laryngeal squamous cell carcinoma

oropharynx cancer

hypopharynx cancer

head and neck squamous cell carcinoma

oral squamous cell carcinoma

Therapies

Pembrolizumab + Radiotherapy

Pembrolizumab

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST